Chronic cerebrospinal venous insufficiency and multiple sclerosis

Archives of Neurology

Volumn 68, Issue 11, 2011, Pages 1379-1384

  Bagert, Bridget A ^a   Marder, Ellen ^b,c   Stüve, Olaf ^b,c  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b Veterans Affairs North Texas Health Care System   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT;

CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; COLOR ULTRASOUND FLOWMETRY; CONFOUNDING VARIABLE; CONTRAST ENHANCEMENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; INTERNAL JUGULAR VEIN; IRON STORAGE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTIVE VALUE; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC ERROR; VEIN BLOOD FLOW; VEIN OCCLUSION;

ANIMALS; CEREBRAL VEINS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; MULTIPLE SCLEROSIS; REGIONAL BLOOD FLOW; SPINAL CORD; VENOUS INSUFFICIENCY;

EID: 81355151105     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.179     Document Type: Review

References (29)

1. Zamboni P, Menegatti E, Galeotti R, et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 2009; 282(1-2):21-27.
2. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009; 80(4):392-399.
3. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50(6):1348-1358, e1-e3.
4. Goodin DS. Disease-modifying therapy in MS: a critical review of the literature, part I: analysis of clinical trial errors. J Neurol. 2004;251(suppl 5):v3-v11.
5. Zivadinov R, Marr K, Ramanathan M, et al. Combined transcranial and extracranial venous Doppler evaluation (CTEVD study): description of the design and interim results of an epidemiological study of the prevalence of chronic cerebrospinal venous insufficiency inMSand related diseases. Poster presented at: Annual Meeting of the American Academy of Neurology; April 15, 2010; Toronto, ON.
6. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 2010;68 (2):173-183.
7. Sundström P, Wåhlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol. 2010;68(2):255-259.
8. Wattjes MP, van Oosten BW, de Graaf WL, et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flowquantification study. J Neurol Neurosurg Psychiatry. 2011;82(4):429-435.
9. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
10. Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab. 2009;29(12):1867-1878.
11. Zivadinov R, Schirda C, Dwyer MG, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol. 2010;29(2):158-175.
12. Haacke EM, Garbern J, Miao Y, Habib C, Liu M. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol. 2010;29(2):149-157.
13. Worthington V, Killestein J, Eikelenboom MJ, et al. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology. 2010;75(18):1617-1622.
14. van Rensburg SJ, van Toorn R. The controversy of CCSVI and iron in multiple sclerosis: is ferritin the key? Neurology. 2010;75(18):1581-1582.
15. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand. 1975;51(2):137-157.
16. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22(2):117-139. (Pubitemid 33771279)
17. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339(5):285-291. (Pubitemid 28366416)
18. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand. 1991; 84(5):403-406.
19. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010;5(9):e12496. doi:10.1371/journal.pone .0012496.
20. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006;59(3):499-503. (Pubitemid 43358070)
21. Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007;64(1):72-75. (Pubitemid 46072426)
22. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62(1):60-65. (Pubitemid 38082871)
23. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001;286(24):3083- 3088. (Pubitemid 34016522)
24. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol. 2006;63(6):839-844. (Pubitemid 43882291)
25. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus [retracted in JAMA. 2005;293(20):2466]. JAMA. 2003;289(12):1533-1536. (Pubitemid 37430292)
26. Khan O, Filippi M, Freedman MS, et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol. 2010;67(3):286-290.
27. US Preventive Services Task Force. US Preventive Services Task Force ratings: grade definitions: guide to clinical preventive services, third edition: periodic updates, 2000-2003. http://www.uspreventiveservicestaskforce. org/3rduspstf /ratings.htm. Accessed March 7, 2011.
28. Reekers JA, Lee MJ, Belli AM, Barkhof F. Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol. 2011;34(1):1-2.
29. Qiu J. Venous abnormalities and multiple sclerosis: another breakthrough claim? Lancet Neurol. 2010;9(5):464-465.